Anti-VEGF-Therapy for neovascular age related Macular Degeneration -therapeutic Strategies

被引：0
|
作者：
机构：
来源：
OPHTHALMOLOGE | 2015年 / 112卷 / 03期
关键词：
ENDOTHELIAL GROWTH-FACTOR; VERTEPORFIN PLUS RANIBIZUMAB; INTRAVITREAL AFLIBERCEPT; CHOROIDAL NEOVASCULARIZATION; PHOTODYNAMIC THERAPY; TRAP-EYE; OUTCOMES; BEVACIZUMAB; TREAT; INJECTIONS;
D O I：
10.1007/s00347-014-3222-x
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：237 / 245
页数：9
相关论文
共 50 条
  • [1] The Anti-VEGF-Therapy in neovascular age-dependent Macular Degeneration: Therapeutic Strategies, Position December 2012
    Pauleikhoff, D.
    Bertram, B.
    Holz, F. G.
    Kirchhof, B.
    Bartz-Schmidt, U.
    Bornfeld, N.
    Bresgen, M.
    Eter, N.
    Friedrichs, W.
    Heimann, H.
    Helbig, H.
    Hoerauf, H.
    Kampik, A.
    Lemmen, K. D.
    Roider, J.
    Ziemssen, F.
    [J]. KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2013, 230 (02) : 170 - 177
  • [2] Anti-VEGF Therapy for Neovascular Age-Related Macular Degeneration: Therapeutic Strategies
    [J]. KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2012, 229 (05) : 541 - 547
  • [3] Morphological changes of macular neovascularization during long-term anti-VEGF-therapy in neovascular age-related macular degeneration
    Pauleikhoff, Daniel
    Gunnemann, Marie-Luise
    Ziegler, Martin
    Heimes-Bussmann, Britta
    Bormann, Eike
    Bachmeier, Isabel
    Yu, Siqing
    Garcia Armendariz, Beatriz
    Pauleikhoff, Laurenz
    [J]. PLOS ONE, 2023, 18 (12):
  • [4] Statement of the German Ophthalmological Society, the Retina Society and the Professional Association of German Ophthalmologists: The Anti-VEGF-Therapy for neovascular age related Macular Degeneration: Therapeutic Strategies (November 2014)
    Pauleikhoff, D.
    Bertram, B.
    Holz, F. G.
    Kirchhof, B.
    Bartz-Schmidt, U.
    Bornfeld, N.
    Bresgen, M.
    Eter, N.
    Friedrichs, W.
    Heimann, H.
    Helbig, H.
    Hoerauf, H.
    Kampik, A.
    Lemmen, K. D.
    Roider, J.
    Ziemssen, F.
    [J]. KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2015, 232 (02) : 202 - 210
  • [5] Macular Atrophy in Patients with Neovascular Age Related Macular Degeneration Undergoing Anti-VEGF Therapy
    Abdelfattah, Nizar Saleh
    Zhang, Hongyang
    Boyer, David S.
    Sadda, Srinivas R.
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [6] Neovascular age-related macular degeneration and anti-VEGF nonresponders
    Sheybani, Arsham
    Almony, Arghavan
    Blinder, Kevin J.
    Shah, Gaurav K.
    [J]. EXPERT REVIEW OF OPHTHALMOLOGY, 2010, 5 (01) : 35 - 41
  • [7] Anti-VEGF Compounds in the Treatment of Neovascular Age Related Macular Degeneration
    Campa, C.
    Harding, S. P.
    [J]. CURRENT DRUG TARGETS, 2011, 12 (02) : 173 - 181
  • [8] Macular Translocation - A Therapeutic Approach for Neovascular Macular Degeneration in the Era of Anti-VEGF Therapy?
    Ziemssen, F.
    Gelisken, F.
    [J]. KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2009, 226 (01) : 31 - 37
  • [9] Resistance to anti-VEGF therapy in neovascular age-related macular degeneration: a comprehensive review
    Yang, Shiqi
    Zhao, Jingke
    Sun, Xiaodong
    [J]. DRUG DESIGN DEVELOPMENT AND THERAPY, 2016, 10 : 1857 - 1867
  • [10] Effect of anti-VEGF therapy on Choroidal Vascularity in subjects with Neovascular Age Related Macular Degeneration
    Jayadev, Chaitra
    Velaga, Swetha
    Nittala, Muneeswar Gupta
    Sinha, Shivani
    Chhablani, Jay
    Sadda, Srinivas R.
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
12345